Clinical trial
Determination of the Sensitifity of ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer - a Monocenter Prospective Open-label Clinical Trial
NCT01395706 is registered in ClinicalTrials.gov with Pulsion Medical Systems SE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Sensitifity of ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer - a Monocenter Prospective Open-label Clinical Trial
- Lead sponsor
- Pulsion Medical Systems SE
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2011
- Completion date
- March 31, 2012
- Enrollment
- 125 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant neoplasm of breast